TG Therapeutics, Inc.
TGTXNASDAQHealthcare● Active
$41.06
+$0.90(+2.24%)
Market Cap$6.3B
P/E Ratio—
52W High$44.65
52W Low$25.28
TG Therapeutics, Inc.（TGTX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · TGTX · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.62B | $0.33B | $0.23B | $0.00B | $0.01B |
| Cost of Revenue | $0.10B | $0.04B | $0.01B | $0.00B | $0.00B |
| Gross Profit | $0.52B | $0.29B | $0.22B | $0.00B | $0.01B |
| Gross Margin %(computed) | 83.66% | 88.30% | 93.95% | 90.48% | 88.19% |
| Operating Expenses | |||||
| R&D Expenses | $0.16B | $0.09B | $0.08B | $0.13B | $0.22B |
| G&A Expenses | $0.23B | $0.15B | $0.12B | $0.10B | $0.13B |
| Total Operating Expenses | $0.39B | $0.25B | $0.20B | $0.22B | $0.35B |
| Operating Income | $0.12B | $0.04B | $0.02B | ($0.22B) | ($0.34B) |
| Operating Margin %(computed) | 20.01% | 12.74% | 8.83% | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.03B | $0.02B | $0.01B | $0.01B | $0.01B |
| Income Before Tax | $0.11B | $0.03B | $0.01B | ($0.22B) | ($0.35B) |
| Income Tax Expense | ($0.34B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.45B | $0.02B | $0.01B | ($0.22B) | ($0.35B) |
| Net Margin %(computed) | 72.56% | 7.11% | 5.42% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $3.10 | $0.16 | $0.09 | $-1.46 | $-2.63 |
| Wtd Avg Shares | 0.14B | 0.15B | 0.14B | 0.14B | 0.13B |
| EBITDA | $0.13B | $0.05B | $0.03B | ($0.21B) | ($0.34B) |
| EBITDA Margin %(computed) | 21.80% | 15.17% | 11.17% | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解TG Therapeutics, Inc.
关于TG Therapeutics, Inc.（TGTX）损益表
TG Therapeutics, Inc.（TGTX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，TGTX实现营收$0.62B，毛利润$0.52B（毛利率83.66%），净利润$0.45B（净利率72.56%）。
常见问题
TGTX · 4 问TG Therapeutics, Inc.（TGTX）2025财年营收为$0.62B，同比up87.3%。
TGTX revenueTGTX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08